Aclarion News - ACON

Company Name	Stock Ticker Symbol	Market	Type
Aclarion Inc	ACON	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0557	-14.18%	0.337	19:59:44

Open Price	Low Price	High Price	Close Price	Prev Close
0.3252	0.32	0.3635	0.337	0.3927

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	09:14	GLOBE	Aclarion’s Nociscan Solution to Play Key Role in..
3/06/2024	16:09	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
3/04/2024	08:00	GLOBE	Aclarion Announces Publication of Compelling Peer-Reviewed..
2/27/2024	15:22	GLOBE	Aclarion Announces Closing of $3.0 Million Public Offering
2/27/2024	14:00	EDGAR2	Form 8-K - Current report
2/27/2024	10:46	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
2/27/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/26/2024	09:15	GLOBE	Aclarion Announces Pricing of $3.0 Million Public Offering
2/23/2024	11:46	EDGAR2	Form S-1/A - General form for registration of securities..
2/21/2024	17:25	EDGAR2	Form 8-K - Current report
2/21/2024	15:02	EDGAR2	Form S-1/A - General form for registration of securities..
2/06/2024	17:32	EDGAR2	Form S-1/A - General form for registration of securities..
2/05/2024	08:00	GLOBE	Aclarion Announces Successful Financings; Plans to Launch..
2/01/2024	17:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/31/2024	17:26	EDGAR2	Form S-1/A - General form for registration of securities..
1/29/2024	06:04	EDGAR2	Form 8-K - Current report
1/23/2024	09:53	EDGAR2	Form 8-K - Current report
1/22/2024	16:48	EDGAR2	Form S-1 - General form for registration of securities under..
1/22/2024	08:00	GLOBE	Aclarion Expands Nociscan Access Into Phoenix With Key..
1/17/2024	08:00	GLOBE	Aclarion Announces Updated Product Release That Expands MRI..
1/12/2024	16:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
1/08/2024	08:00	GLOBE	Aclarion and ATEC Execute Strategic Partnership Agreement to..
1/04/2024	08:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/04/2024	08:00	EDGAR2	Form 8-K - Current report
1/02/2024	12:00	GLOBE	Aclarion Announces Reverse Stock Split
12/29/2023	06:30	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/19/2023	16:30	EDGAR2	Form 8-K - Current report
12/11/2023	16:55	EDGAR2	Form S-1 - General form for registration of securities under..
11/27/2023	08:00	GLOBE	Aclarion Announces Key Commercial Milestone With Completion..
11/22/2023	16:01	EDGAR2	Form 8-K - Current report
11/16/2023	16:58	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/13/2023	06:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/08/2023	08:00	GLOBE	Aclarion Announces Achievement of Goal to Enroll 10 Leading..
11/06/2023	08:00	GLOBE	Aclarion Expands Immediate Nociscan Access Into New York..
11/01/2023	16:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/01/2023	08:00	GLOBE	Aclarion Presents at the NIH HEAL Initiative Fall Meeting
10/30/2023	17:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
10/25/2023	08:30	GLOBE	Aclarion Announces Signing of Commercial Agreement With..
10/24/2023	08:45	GLOBE	Aclarion Announces Nociscan® Cost-Effectiveness Poster..
10/23/2023	08:55	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/23/2023	07:00	GLOBE	Aclarion Announces Signing Strategic Partnership Letter of..
10/23/2023	06:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
10/20/2023	15:08	EDGAR2	Form S-1/A - General form for registration of securities..
10/10/2023	15:34	EDGAR2	Form S-1 - General form for registration of securities under..
10/10/2023	08:30	EDGAR2	Form 8-K - Current report
10/02/2023	08:00	GLOBE	Aclarion Provides Updated Investor Presentation and..
9/28/2023	07:48	EDGAR2	Form 8-K - Current report
9/07/2023	16:01	EDGAR2	Form 8-K - Current report
8/31/2023	16:01	EDGAR2	Form 8-K - Current report
8/25/2023	16:42	EDGAR2	Form 8-K - Current report